Drug Type Small molecule drug |
Synonyms FAUC 329 |
Target |
Action antagonists |
Mechanism D3 receptor antagonists(Dopamine D3 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H29N5O2 |
InChIKeyMBSIGRZACGJWRM-UHFFFAOYSA-N |
CAS Registry474432-48-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nervous System Diseases | Preclinical | Germany | 01 Jul 2017 | |
Unspecified drug dependence | Preclinical | Germany | 01 Jul 2017 |